呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2020 ATS临床实践指南：COPD的药物治疗

2020-04-13 美国胸科学会 Am J Respir Crit Care Med. 2020 Apr 13.

COPD慢性阻塞性肺疾病（COPD）

2020年4月，美国胸科学会(ATS)发布了COPD的药物治疗指南，本文主要针对慢性阻塞性肺疾病（COPD）的药物治疗提供指导建议，共涉及6个临床问题。

中文标题：

2020 ATS临床实践指南：COPD的药物治疗

英文标题：

Pharmacologic Management of COPD: An Official American Thoracic Society Clinical Practice Guideline.

发布机构：

美国胸科学会

发布日期：

2020-04-13

简要介绍：

2020年4月，美国胸科学会(ATS)发布了COPD的药物治疗指南，本文主要针对慢性阻塞性肺疾病（COPD）的药物治疗提供指导建议，共涉及6个临床问题。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ATS临床实践指南：COPD的药物治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c414f1c00189a691, title=2020 ATS临床实践指南：COPD的药物治疗, enTitle=Pharmacologic Management of COPD: An Official American Thoracic Society Clinical Practice Guideline., guiderFrom=Am J Respir Crit Care Med. 2020 Apr 13., authorId=0, author=, summary=2020年4月，美国胸科学会(ATS)发布了COPD的药物治疗指南，本文主要针对慢性阻塞性肺疾病（COPD）的药物治疗提供指导建议，共涉及6个临床问题。, cover=https://img.medsci.cn/2020422/1587556167723_2020535.jpg, journalId=0, articlesId=null, associationId=181, associationName=美国胸科学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Apr 13 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年4月，美国胸科学会(ATS)发布了COPD的药物治疗指南，本文主要针对慢性阻塞性肺疾病（COPD）的药物治疗提供指导建议，共涉及6个临床问题。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=295, tagName=COPD), TagDto(tagId=25771, tagName=慢性阻塞性肺疾病（COPD）)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=295, guiderKeyword=COPD, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5710, appHits=381, showAppHits=43, pcHits=1793, showPcHits=5350, likes=1, shares=17, comments=4, approvalStatus=1, publishedTime=Wed Apr 22 20:14:38 CST 2020, publishedTimeString=2020-04-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Apr 22 19:49:35 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:38:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ATS临床实践指南：COPD的药物治疗.pdf)])
2020 ATS临床实践指南：COPD的药物治疗.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082197, encodeId=b376108219e0b, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Mon Dec 20 20:17:26 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014369, encodeId=921d1014369ea, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86335136108, createdName=1466784bm59暂无昵称, createdTime=Fri Sep 03 20:10:23 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946608, encodeId=51e8946608e1, content=值得中国呼吸科医生学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909a1557445, createdName=zhangyihong, createdTime=Mon Mar 08 23:19:02 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2021-12-20 ms2000001285500485

    太好了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082197, encodeId=b376108219e0b, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Mon Dec 20 20:17:26 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014369, encodeId=921d1014369ea, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86335136108, createdName=1466784bm59暂无昵称, createdTime=Fri Sep 03 20:10:23 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946608, encodeId=51e8946608e1, content=值得中国呼吸科医生学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909a1557445, createdName=zhangyihong, createdTime=Mon Mar 08 23:19:02 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2021-09-03 1466784bm59暂无昵称

    太棒了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082197, encodeId=b376108219e0b, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Mon Dec 20 20:17:26 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014369, encodeId=921d1014369ea, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86335136108, createdName=1466784bm59暂无昵称, createdTime=Fri Sep 03 20:10:23 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946608, encodeId=51e8946608e1, content=值得中国呼吸科医生学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909a1557445, createdName=zhangyihong, createdTime=Mon Mar 08 23:19:02 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2021-03-08 zhangyihong

    值得中国呼吸科医生学习

    0

相关指南

2018 丹麦呼吸学会意见书：慢性进行性非恶性肺病患者的姑息治疗

丹麦呼吸学会(Danish respiratory society) · 2018-10-16

2018年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读

暂未更新 · 2017-12-26

2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2017-11-01

慢性阻塞性肺疾病急性加重的治疗策略：2017欧洲呼吸学会/美国胸科学会指南解读

暂未更新 · 2017-09-20

2017 ERS/ATS慢性阻塞性肺疾病急性加重管理指南解读

暂未更新 · 2017-05-30

2016 GOLD 慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略（更新版）

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2017-03-24

拓展阅读

2010 GOLD 慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2010-01-01

2010JRS 日本呼吸学会慢性阻塞性肺疾病（COPD）诊治指南(概述)

日本呼吸学会(JRS,the Japanese Respiratory Society) · 2010-02-01

2011 GOLD 慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2011-12-01

慢性阻塞性肺疾病急性加重（AECOPD）诊治中国专家共识（草案）

中国呼吸科专家组（统称） · 2012-11-01

2013 GOLD 慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略（修订版）

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2013-02-13

2013 西班牙COPD指南：慢性阻塞性肺疾病基于临床表型的分级和治疗

西班牙肺病和胸外科学会(SEPAR,Spanish Society of Pneumology and Thoracic Surgery) · 2013-03-20